DRESDEN, Germany, May. 31, 2023 — denovoMATRIX GmbH, an innovator in cell and gene therapy manufacturing, unveiled the broadening of its product portfolio with the launch of its first stem cell product at the annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Paris, France. [Read more…]

The collaboration includes the development, commercialization and supply of a breakthrough platform based on SomesTech nanoengineering technology strengthened and validated by convEyXO to enable loading of exosomes capable to delivering bioactive compounds in a targeted way.

[Read more…]

Overland Park, KS – Ronawk, a leading biotechnology company, proudly announces the launch of STELLα, a state-of-the-art non-clinical contract research organization (CRO) dedicated to driving innovation in the life sciences industry. The addition of STELLα to Ronawk’s portfolio represents a significant milestone in the company’s growth and expansion, further solidifying its position as a strategic contributor to the region’s growing biotech ecosystem. [Read more…]

The findings of this study suggest that stem cells could have major implications for treating MS and reversing patient disability even after significant progression.

The study, from the Tisch MS Research Center of New York, is the first to link stem cells with a broad array of improvements. Progressive MS patients demonstrated better outcomes in walking speeds, gray matter volume, bladder function, and biomarker indicators.

[Read more…]

BENGALURU, KARNATAKA, INDIA, MAY 04, 2023 – Oncofocus Solutions, a management consulting firm established in 2014 to cater to the business intelligence needs in the Oncology domain, is offering the live demo of Novus AI, its cutting-edge AI-powered conference intelligence platform. [Read more…]